Skip to content
Lower risk Drug recall · FDA · Published December 4, 2018

Epic Pharma Estradiol Tablets Recall: Foreign Tablet Found in Bottle

Epic Pharma recalls 100-count Estradiol 2 mg tablets due to a foreign tablet found in some bottles. This is a safety issue for patients using prescription hormone therapy.

🇺🇸 FDA recall #D-0297-2019DrugEpic Pharma ›
Take action

Contact the company

Recalling firmEpic Pharma, LLC22715 N Conduit Ave · Laurelton, NY 11413-3134
✎ GovInfoNow plain-language explainer

Epic Pharma is recalling 100-count Estradiol 2 mg tablets because a single foreign tablet was found in some pharmacy dispensed bottles. This could pose a risk if the foreign tablet is taken with the intended medication. Read more at govinfonow.com/recall/39392-epic-pharma-estradiol-tablets-recall-foreign-tablet-found-in-bottle.

Source Summary by GovInfoNow · govinfonow.com/recall/39392-epic-pharma-estradiol-tablets-recall-foreign-tablet-found-in-bottle · Updated October 5, 2026 · FDA enforcement record: FDA #D-0297-2019

Cite this page

“Epic Pharma Estradiol Tablets Recall: Foreign Tablet Found in Bottle.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39392-epic-pharma-estradiol-tablets-recall-foreign-tablet-found-in-bottle. Based on FDA recall #D-0297-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0297-2019%22&limit=1).

The FDA announced on Dec. 4, 2018, that Epic Pharma LLC voluntarily recalled Estradiol Tablets, USP, 2 mg, due to the presence of a foreign tablet. The recall affects 2,976 bottles distributed nationwide.

How to tell if you have it

  • Brand: Epic Pharma
  • Product: Estradiol Tablets, USP, 2 mg, 100-count bottle
  • NDC: 42806-089-01
  • Lot #: 18103A
  • Expiration: 6/20
  • Quantity: 2,976 bottles

The hazard

The hazard involves the presence of a foreign tablet or capsule. A single foreign tablet was found in a pharmacy-dispensed bottle of 30 Estradiol 2 mg tablets.

Context

GovInfoNow's records show Epic Pharma, LLC has one other recall on record since Sept. 26, 2019. Other recent recalls of similar products include Annora Pharma Pitavastatin Tablets 2mg Recall (Feb. 3, 2026), Golden State Baclofen Tablets Recall (Nov. 26, 2025), and Granules Pharmaceuticals Trazodone 50mg Recall (Jan. 26, 2026).

How to tell if you have this one

Check for the product name 'Estradiol Tablets, USP, 2 mg, 100-count bottle' with NDC 42806-089-01 and lot number 18103A, which expires June 2020.

  • Brand
    Epic Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product

    Look for the NDC 42806-089-01 and lot number 18103A on the bottle label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Dec 4, 201812. FDA classified it Class II: Dec 14, 201823. Published in FDA’s Enforcement Report: Dec 26, 201834. FDA terminated the recall: Feb 9, 2021420182021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0297-2019 (December 4, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0297-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA